ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, ...
Hold Rating Given for Zanzalintinib Based on STELLAR-001 Trial Outcomes
Stifel Nicolaus analyst Stephen Willey has maintained their neutral stance on EXEL stock, giving a Hold rating today.Invest with Confidence: ...
Stifel Nicolaus Keeps Their Buy Rating on ioneer Limited (GSCCF)
Stifel Nicolaus analyst Cole McGill maintained a Buy rating on ioneer Limited (GSCCF – Research Report) today and set a price target of A$0.40.
Stifel Nicolaus Raises Planet Fitness (NYSE:PLNT) Price Target to $90.00
Planet Fitness (NYSE:PLNT – Get Free Report) had its target price upped by research analysts at Stifel Nicolaus from $85.00 ...
Stifel Nicolaus Cuts Werner Enterprises (NASDAQ:WERN) Price Target to $30.00
Werner Enterprises (NASDAQ:WERN – Free Report) had its price target decreased by Stifel Nicolaus from $32.00 to $30.00 in a research note issued to investors on Wednesday,Benzinga reports. Stifel ...
Stifel cuts P&G stock price target to $161, maintains hold rating
Stifel analysts adjusted their outlook for Procter & Gamble (NYSE:PG) shares, reducing the price target from $167.00 to ...
Stifel upgrades Canadian National stock, highlights growth potential in 2025
Stifel analysts announced an upgrade for Canadian National Railway (TSX:CNR) (NYSE:CNI) stock, changing its status from Hold to Buy, albeit with a reduced price target of $120.00, down from the ...
Canada’s Eight Capital to Shut Down as Stifel Swoops In for Bankers
Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.